Skip to content

Changes of iris morphological feature after anti-VEGF intravitreal injection

Changes of iris morphological feature after anti-VEGF intravitreal injection - Changes of iris morphological feature after anti-VEGF intravitreal injection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000029378
Enrollment
30
Registered
2017-10-02
Start date
2017-09-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Branch retinal vein occlusion,Central retinal vein occlusion

Interventions

None listed

Sponsors

saneikai tsukazaki Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with Branch retinal vein occlusion and Central retinal vein occlusion 2)history of no anti-VEGF intravireal injection 3)clear cross-sectional images were already obtained using the anterior segment mode and angle mode on swept-source(SS)-AsOCT(SS-1000 CASIATM,TOMEY,Nagoya,Japan).

Exclusion criteria

Exclusion criteria: Except for above criteria

Design outcomes

Primary

MeasureTime frame
Iris thickness at 1mm and 2mm from pupil edge,iris length were analyzed at baseline, 1M, 3M, 6M, 12M after anti-VEGF intravitreal injection.

Countries

Japan

Contacts

Public ContactTomoaki Sonobe

saneikai tsukazaki Hospital Ophthalmology

t.sonobe@tsukazaki-eye.net0792728555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026